Dr. Bing Su graduated from Peking University in Beijing in 1984 with a BS degree. He was awarded a China-US Biochemistry and Molecular Biology Application (CUSBEA) fellowship in 1985 for studying at Yale where he obtained his PhD degree in 1991. Dr. Su did his postdoctoral training with Dr. Michael Karin at UCSD and started his independent academic career in 1995 at the University of Texas M.D. Anderson Cancer Center where he became a tenured Full Professor in 2006. Dr. Su moved to Yale University in 2006 as a tenured Associate Professor at the Department of Immunobiology until 2015. Dr. Su currently serves as the Director of Shanghai Institute of Immunology and Chair of Department of Immunology and Microbiology at Shanghai Jiao Tong University (SJTU) School of Medicine. Dr. Su also holds a KC Wong Chair Professor at SJTU and a Distinguished Chair Professorship at Central South University and an adjunct Professor at Shanghai University of Chinese Medicine in China. Dr. Su’s research focuses on the mammalian target of rapamycin (mTOR) and the mitogen activated protein kinases (MAPKs). Dr. Su has published over 154 original articles in journals like Cell, Nature, Nature Immunology, Immunity etc and his research has been funded by NIH, DOD, AHA, the Leukemia and Lymphoma Society, and Ministry of Science and Technology (Chief Scientist), National Natural Science Foundation of China (NSFC) and Shanghai Science and Technology Commission.
« Go Back